JP2007117090A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007117090A5 JP2007117090A5 JP2006290414A JP2006290414A JP2007117090A5 JP 2007117090 A5 JP2007117090 A5 JP 2007117090A5 JP 2006290414 A JP2006290414 A JP 2006290414A JP 2006290414 A JP2006290414 A JP 2006290414A JP 2007117090 A5 JP2007117090 A5 JP 2007117090A5
- Authority
- JP
- Japan
- Prior art keywords
- cys401
- cys368
- cys349
- cys352
- terminus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 201000005404 rubella Diseases 0.000 description 5
- 239000000427 antigen Substances 0.000 description 3
- 102000036639 antigens Human genes 0.000 description 3
- 108091007433 antigens Proteins 0.000 description 3
- 239000012634 fragment Substances 0.000 description 3
- 238000001514 detection method Methods 0.000 description 2
- 125000000539 amino acid group Chemical group 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 210000004897 n-terminal region Anatomy 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP05109993 | 2005-10-26 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2007117090A JP2007117090A (ja) | 2007-05-17 |
| JP2007117090A5 true JP2007117090A5 (enExample) | 2008-04-24 |
| JP4116054B2 JP4116054B2 (ja) | 2008-07-09 |
Family
ID=37965193
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006290414A Active JP4116054B2 (ja) | 2005-10-26 | 2006-10-25 | シャペロン融合タンパク質としての風疹ｅ１エンベロープタンパク質変異体の組換え発現、可溶性で天然様かつ免疫反応性の抗原コンホメーションへのそのリフォールディングならびに抗風疹抗体の検出におけるその用途 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US7604935B2 (enExample) |
| JP (1) | JP4116054B2 (enExample) |
| AT (1) | ATE491030T1 (enExample) |
| CA (1) | CA2562738C (enExample) |
| DE (1) | DE602006018694D1 (enExample) |
| ES (1) | ES2356383T3 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4871960B2 (ja) * | 2006-01-03 | 2012-02-08 | エフ．ホフマン−ラ ロシュ アーゲー | 優れたシャペロン活性およびフォールディング活性を有するキメラ融合タンパク質 |
| EP2178896A1 (en) * | 2007-07-31 | 2010-04-28 | The Johns Hopkins University | Polypeptide-nucleic acid conjugate for immunoprophylaxis or immunotherapy for neoplastic or infectious disorders |
| CN101939330B (zh) * | 2007-12-13 | 2014-06-04 | 霍夫曼-拉罗奇有限公司 | 新型风疹e1包膜蛋白变体及其在检测抗风疹抗体中的用途 |
| AR086250A1 (es) * | 2011-05-05 | 2013-11-27 | Hoffmann La Roche | Polipeptido de fusion presentador de una secuencia de aminoacidos y utilizacion del mismo |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2095818B (en) | 1981-03-27 | 1985-10-02 | Exxon Research Engineering Co | Staged adsorption/resorption heat pump |
| EP0299673A1 (en) | 1987-07-08 | 1989-01-18 | London Biotechnology Limited | Rubella E1 glycoprotein antigens |
| JP2001501093A (ja) | 1996-09-26 | 2001-01-30 | メディカル リサーチ カウンシル | シャペロン断片 |
| DE19649390A1 (de) | 1996-11-29 | 1998-06-04 | Boehringer Mannheim Gmbh | Antigenspezifischer IgG-Nachweis |
| ATE522603T1 (de) | 2001-06-22 | 2011-09-15 | Hoffmann La Roche | Löslicher komplex, der retrovirale oberflächen- glykoproteine und fkpa oder slyd enthält |
-
2006
- 2006-10-23 US US11/584,887 patent/US7604935B2/en active Active
- 2006-10-23 CA CA2562738A patent/CA2562738C/en active Active
- 2006-10-24 ES ES06022216T patent/ES2356383T3/es active Active
- 2006-10-24 DE DE602006018694T patent/DE602006018694D1/de active Active
- 2006-10-24 AT AT06022216T patent/ATE491030T1/de active
- 2006-10-25 JP JP2006290414A patent/JP4116054B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2005120106A5 (enExample) | ||
| JP2015212284A5 (enExample) | ||
| RU2018130075A (ru) | Белки специфического связывания и их применения | |
| JP2003522200A5 (enExample) | ||
| NO20063026L (no) | Antistoffer | |
| JP2018033454A5 (enExample) | ||
| JP2010523994A5 (enExample) | ||
| ATE387629T1 (de) | Gemeinsame epitope von antigenen aus einer multigen-familie | |
| MX2011008759A (es) | Medios y metodos para fabricar neurotoxina altamente pura. | |
| Takacs et al. | Preparation of clinical grade proteins produced by recombinant DNA technologies | |
| Croft et al. | Use of Luminex xMAP-derived Bio-Plex bead-based suspension array for specific detection of PPV W and characterization of epitopes on the coat protein of the virus | |
| JP2021130676A5 (enExample) | ||
| CN118420750A (zh) | 抗猴痘病毒a35r蛋白的单克隆抗体8d7或其抗体片段 | |
| NZ547629A (en) | Antibodies binding to conformationally discriminating epitopes of human IGG Fc receptor IIb and IIb | |
| WO2009074318A3 (en) | Novel rubella e1 envelope protein variants and their use in the detection of anti-rubella antibodies | |
| HK1201281A1 (en) | Canine/feline cd20 binding epitope and compositions for binding thereto | |
| CN118496349A (zh) | 抗猴痘病毒a35r蛋白的单克隆抗体2d7或其抗体片段 | |
| CN104558108A (zh) | 小反刍兽疫病毒n蛋白的线性抗原表位最小基序肽 | |
| JP2010279373A5 (enExample) | ||
| CN103933560A (zh) | 一种应用Ii-Key活性四肽携带法氏囊VP2和新城疫HN抗原肽表位嵌合疫苗的制备方法 | |
| WO2014153168A4 (en) | Porcine astrovirus sequences and uses thereof | |
| CA2542104A1 (en) | Method for the identification of epitopes related to immunogenicity in biopharmaceuticals | |
| JP2005512016A5 (enExample) | ||
| JP2009517015A5 (enExample) | ||
| WO2004000238A3 (en) | Utilization of mhc class ii binding motifs in immunization to produce immune serum, monoclonal antibodies and vaccines |